Hospira, Inc. (HSP) Tops Q2 EPS by 16c; Guides FY14 EPS Above Consensus

Hospira, Inc. (NYSE: HSP) reported Q2 EPS of $0.72, $0.16 better than the analyst estimate of $0.56. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.05 billion.

Hospira, Inc. sees FY2014 EPS of $2.30-$2.50, versus the consensus of $2.22.

For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Super Micro Computer (SMCI) Falls 6%
• Oilfield firm SLB's profit rises on international drilling demand